Vision Support II
Supports Optimal Eye Health*
- Promotes healthy eye structure and function
- Aids in the support of eye fatigue
- Helps protect the eye from damage caused by light
$54.96 — or subscribe and get 20% off
Eyesight is one of our most important senses: 80% of what we perceive comes through our sense of sight. That’s why keeping your eyes healthy will improve your overall quality of life!
Because eyes are compound of very sensitive tissues, there are many different factors that can damage our eyes, as research has shown. The sun’s ultraviolet rays and blue light—present in the majority of our electronic devices–both have a negative impact on our eyes, especially when they have been exposed for extended periods of time.
Eye damage associated with UV rays and blue light may include many abnormalities. Lutein and zeaxanthin are pigments that help protect eyes’ sensitive tissues from light damage.
Our formula benefits from the powerful impact of both lutein and zeaxanthin combined with benfotiamine and astaxanthin. Research has shown that lutein and zeaxanthin help protect the lens and macula from light. Benfotiamine supports the prevention of the formation of AGEs (advanced glycation end-products) and visual disturbances. Astaxanthin has been clinically shown to reduce eye fatigue related to extended exposure to computer screens.
By protecting your eyes, you’ll promote healthy vision function while reducing the likelihood of developing vision ailments. You can boost the effectiveness of Vision Support II by adding a complete, high-quality multivitamin/mineral to your supplement and nutritional intake.
AOR’s Vision Support II formula includes a variety of nutrients that support optimal vision and function of the lens and macula in the eye. Vision Support II is an ideal choice to promote long-term eye health.
Vision Support II is a combination of ingredients based on the latest scientific research to support eye health.*
AOR™ guarantees that all ingredients have been declared on the label. Made without wheat, gluten, nuts, peanuts, sesame seeds, mustard, dairy, eggs, fish or shellfish.
Take 2 softgels per day with food, or as directed by a qualified health care practitioner.
Do not use if you are pregnant or lactating. Consult your physician before use if you have a medical condition, or if you’re taking any medication. Keep out of reach of children.
- Eye health
- Eye fatigue
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
† Daily value not established.
Other Ingredients: extra virgin olive oil, safflower oil, softgel (gelatin, glycerin and caramel colour), corn oil and mixed tocopherols.
Bone RA, et al. Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J Nutr. 2003 Apr;133(4):992-8. Erratum in: J Nutr. 2003 Jun;133(6):1953.
Hammes HP, Du X, Edelstein D, Taguchi T, Matsumura T, Ju Q, Lin J, Bierhaus A, Nawroth P, Hannak D, Neumaier M, Bergfeld R, Giardino I, Brownlee M. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med. 2003 Mar;9(3):294-9.
Hashim Z, Zarina S.Advanced glycation end products in diabetic and non-diabetic human subjects suffering from cataract. Age (Dordr). 2011 Sep;33(3):377-84.
Nagai R, Shirakawa JI, Ohno RI, Moroishi N, Nagai M. Inhibition of AGEs formation by natural products.
Amino Acids. 2013 Mar 17.
Nagaki Y, et al. Effects of Astaxanthin on accommodation, critical flicker fusions, and pattern evoked potential in visual display terminal workers. J. Trad. Med. 2002, 19(5): 170-173.
Nagaraj RH, Linetsky M, Stitt AW.The pathogenic role of Maillard reaction in the aging eye. Amino Acids. 2012 Apr;42(4):1205-20.
Sakimoto T, et al. Clinical study with black soybean extract on ocular function. Japanese Review of Clinical Ophthalmology 2004, V.98;N.11;Pg.982-986
Scharrer A, Ober M. Anthocyanosides in the treatment of retinopathies. Klin Monatsbl Augenheilkd 1981 May; 178(5): 386-9.